of 2022 
to EUR 67.7 million at the end of 2023. Research and development 
Research and development expenses related to 
the Group's businesses amounted to EUR 51.3 
million (12.0% of sales) in 2023 less EUR 3.4 
million of research tax credit. At IBA, research expenses are recognized 
directly in the income statement. For BE GAAP 
purposes, development costs are recognised as 
intangible assets and amortised linearly over 3 
years, on a prorata temporis basis while 
research 
expenses 
are 
ca